Cargando…
Hepatitis B Virus Exploits ERGIC-53 in Conjunction with COPII to Exit Cells
Several decades after its discovery, the hepatitis B virus (HBV) still displays one of the most successful pathogens in human populations worldwide. The identification and characterization of interactions between cellular and pathogenic components are essential for the development of antiviral treat...
Autores principales: | Zeyen, Lisa, Döring, Tatjana, Prange, Reinhild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464876/ https://www.ncbi.nlm.nih.gov/pubmed/32806600 http://dx.doi.org/10.3390/cells9081889 |
Ejemplares similares
-
Host Cell Rab GTPases in Hepatitis B Virus Infection
por: Zeyen, Lisa, et al.
Publicado: (2018) -
Rab33B Controls Hepatitis B Virus Assembly by Regulating Core Membrane Association and Nucleocapsid Processing
por: Bartusch, Christina, et al.
Publicado: (2017) -
Targeting of protein ERGIC-53 to the ER/ERGIC/cis-Golgi recycling pathway
Publicado: (1995) -
The Lectin ERGIC-53 Goes Viral
por: Pasquato, Antonella, et al.
Publicado: (2013) -
TANGO1 assembles into rings around COPII coats at ER exit sites
por: Raote, Ishier, et al.
Publicado: (2017)